+47 958 10 155 post@nfts.no

Vi har fått følgende forespørsel fra PatientView:

STUDY ON THE CORPORATE REPUTATION OF THE PHARMACEUTICAL INDUSTRY IN 2014—A PATIENT PERSPECTIVE

Dear Norsk Forening for Tuberøs Sklerose,

For the 4th year, PatientView is ASKING HEALTH CAMPAIGNERS ACROSS THE
WORLD TO HELP COMPILE THE ANNUAL CORPORATE REPUTATION INDEX OF PHARMA.

  • The Index is taken seriously by the pharma industry as part of its efforts to become more patient-friendly.
  • The results of this 2014 survey will show you how your colleagues rate the world’s various pharmaceutical companies in 2014 (whether good or bad).

ABOUT THE QUESTIONNAIRE

The survey is open to ANY HEALTH ADVOCACY ORGANISATION WORLDWIDE.
The survey has ONLY 10 VERY SIMPLE QUESTIONS, and
will probably take no more than 10-15 MINUTES of your time to complete.
The survey is ANONYMOUS, unless you prefer to specify otherwise.

The survey’s closing date is FRIDAY, 2ND JANUARY 2015.

TO ENTER THE SURVEY, PLEASE CLICK ON THE FOLLOWING LIVE LINK:
Til undersøkelsen: STUDY ON THE CORPORATE REPUTATION OF PHARMA IN 2014 >> 

To thank you for your participation in this study …
… all respondents to any PatientView study get a final copy of the resulting report (if they wish).

IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT:

Dr Alex Wyke, CEO, PatientView, email: alexwyke@patient-view.com

 

A BRIEF STATEMENT OF CLARIFICATION

This study intends to determine how patient groups around the world
perceive the pharmaceutical industry, with the aim of improving
standards throughout the industry to levels that are satisfactory to
patients.

The study is paid for solely by PatientView, a UK-based research and
publishing group that specialises in studying trends in the
patient-advocacy movement, and which passes valuable information back to
patient groups. All NGOs participating in the study are sent a free copy
of the report on the survey results (if they wish to receive it).
PatientView is then able to fund the exercise by selling the report to
any pharma companies that wish to read it. Further information about
PatientView can be found at our website: www.patient-view.com